MAPK3 and breast cancer: This mechanism has indeed been observed in an in vivo mouse model of the basal-type breast cancer, in which α3β1 promotes proliferation and survival of tumor cells through activation of the FAK-PAK1-ERK1/2 signaling pathway [18].